Correction to: Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants. (2020)
Attributed to:
Integrating innovative technologies for genotyping and phenotyping in stratified medicine
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s40291-020-00479-2
PubMed Identifier: 32572786
Publication URI: http://europepmc.org/abstract/MED/32572786
Type: Journal Article/Review
Volume: 24
Parent Publication: Molecular diagnosis & therapy
Issue: 4
ISSN: 1177-1062